Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 2/20 | 0.46 |
| ▸ | MGLL | Q99685 | 13/20 | 0.42 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 5/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 5/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CCR6 | P51684 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20681587 | 0.83 | KMT2A (0.39) | KMT2AATMMGLLDDAH1FAAH | |
| SCHEMBL29000169 | 0.82 | KMT2A (0.50) | KMT2AATMPKMMAPK1ALDH1A1 | |
| SCHEMBL1608836 | 0.74 | ALDH1A1 (0.46) | KMT2AMGLLMAPK1ALDH1A1HPGD | |
| SCHEMBL29211477 | 0.73 | KMT2A (0.42) | KMT2AATMPKMMAPK1ALDH1A1 | |
| SCHEMBL1081993 | 0.71 | PTGS1 (0.38) | KMT2AATMTDP1PKMMAPK1 | |
| SCHEMBL326688 | 0.71 | PKM (0.49) | KMT2AMGLLDDAH1FAAHHSP90AA1 | |
| SCHEMBL26623027 | 0.70 | ALDH1A1 (0.67) | KMT2AMGLLDDAH1FAAHHSP90AA1 | |
| SCHEMBL8510655 | 0.68 | MGLL (0.49) | MGLLDDAH1FAAHHSP90AA1TDP1 | |
| SCHEMBL28882413 | 0.68 | HSP90AA1 (0.43) | KMT2AATMMGLLDDAH1FAAH | |
| SCHEMBL15782481 | 0.68 | MGLL (0.48) | KMT2AATMMGLLDDAH1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2249873-B1 | CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO A POLYANION FOR THE TREATMENT OF AIDS | PASTEUR INSTITUT (FR) | 2016-11-16 | — | — | EP | claimed |
| EP-2284284-B1 | Antigen detection kit and method | KOREA INST SCI & TECH (KR) | 2015-02-25 | — | — | EP | claimed |
| US-20100261244-A1 | METHOD FOR IMMOBILIZING BIO-MATERIAL ON TITANIUM DIOXIDE NANOPARTICLES AND TITANIUM DIOXIDE NANOPARTICLES IMMOBILIZED BY BIO-MATERIAL | ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) | 2010-10-14 | — | — | US | claimed |
| WO-2009078513-A1 | METHOD FOR IMMOBILIZING BIO-MATERIAL ON TITANIUM DIOXIDE NANOPARTICLES AND TITANIUM DIOXIDE NANOPARTICLES IMMOBILIZED BY BIO-MATERIAL | ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) | 2009-06-25 | — | — | WO | claimed |
| EP-0649857-B1 | Peptide having inflammation affinity and radioactive diagnostic containing the same | NIHON MEDIPHYSICS CO LTD (JP) | 1999-01-20 | — | — | EP | claimed |
| US-9297800-B2 | Biomaterial construct, its producing method, biomaterial support, target material purifying method, affinity chromatography container, separation chip, analyzing method and analyzing separator for target material, biomaterial complex, and its support, sensor chip, solid support with biomaterial fixed thereon | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-03-29 | — | — | US | disclosed |
| US-9273140-B2 | Antibody for detecting DNA damage in cells utilizing cell membrane surface antigen Ly6D | FUJITA HEALTH UNIVERSITY (JP) | 2016-03-01 | — | — | US | disclosed |
| EP-2515112-B1 | Method for electrochemically detecting analyte | SYSMEX CORP (JP) | 2015-08-12 | — | — | EP | disclosed |
| EP-2339342-B1 | Biomaterial structure, method of producing the same and uses thereof | LSI MEDIENCE CORP (JP) | 2014-11-12 | — | — | EP | disclosed |
| CN-102471371-B | Homing peptides for tumor vasculature | UNIV HONG KONG CHINESE | 2014-04-23 | — | — | CN | disclosed |
| US-20140004536-A1 | METHOD FOR DETECTING CELLULAR DNA DAMAGE AND ANTIBODY AGAINST CELL SURFACE ANTIGEN RESPONSIVE TO DNA STRAND BREAKS | PERSEUS PROTEOMICS INC. (JP) | 2014-01-02 | — | — | US | disclosed |
| US-20120267258-A1 | METHOD FOR ELECTROCHEMICALLY DETECTING ANALYTE | NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) | 2012-10-25 | — | — | US | disclosed |
| US-20080044925-A1 | Biomaterial Construct, Its Producing Method, Biomaterial Support, Target Material Purifying Method, Affinity Chromatography Container, Separation Chip, Analyzing Method and Analyzing Separator for Target Material, Biomaterial Complex, and Its Support, Sensor Chip, Solid Support with Biomaterial Fixed Thereon | LSI MEDIENCE CORPORATION (JP) | 2008-02-21 | — | — | US | disclosed |
| US-20080038329-A1 | T-CELL ACTIVATING AGENT | NOF CORPORATION (JP) | 2008-02-14 | — | — | US | disclosed |
| EP-1813946-A1 | BIOMATERIAL CONSTRUCT, ITS PRODUCING METHOD, BIOMATERIAL SUPPORT, TARGET MATERIAL PURIFYING METHOD, AFFINITY CHROMATOGRAPHY CONTAINER, SEPARATION CHIP, ANALYZING METHOD AND ANALYZING SEPARATOR FOR TARGET MATERIAL, BIOMATERIAL COMPLEX, AND ITS SUPPORT, SENSOR CHIP, SOLID SUPPORT WITH BIOMATERIAL FIXE | Mitsubishi Chemical Corporation (JP) | 2007-08-01 | — | — | EP | disclosed |
| US-20060071203-A1 | Coating composition and optical article | TOKUYAMA CORPORATION (JP) | 2006-04-06 | — | — | US | disclosed |
| US-20050266066-A1 | Phospholipid membrane preparation | NOF CORPORATION (JP) | 2005-12-01 | — | — | US | disclosed |
| EP-1568739-A1 | COATING COMPOSITION AND OPTICAL ARTICLE | Tokuyama Corporation (JP) | 2005-08-31 | — | — | EP | disclosed |
| US-20050049313-A1 | Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode | DAIICHI PURE CHEMICALS CO., LTD. | 2005-03-03 | — | — | US | disclosed |
| US-5756363-A | Liposome reagent for immunoagglutination and immunoanalytical method | NISSUI PHARMACEUTICAL CO., LTD. (JP) | 1998-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050049313-A1 | Electron mediator, electron mediator immobilized electrode, and biofuel cell using the electrode | SQOR, ME3, VAT1 | KMT2A 2726/4885ATM 3851/4885MGLL 2836/4885 |
| US-20140004536-A1 | METHOD FOR DETECTING CELLULAR DNA DAMAGE AND ANTIBODY AGAINST CELL SURFACE ANTIGEN RESPONSIVE TO DNA STRAND BREAKS | DCLRE1A, DDB1, DNASE1L3 | KMT2A 3559/4885ATM 426/4885MGLL 4427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.